PATENT CLAIM ANALYSIS

Application Number: 16125124
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "319000"]

Abstract:
The disclosure generally relates to pharmaceutical compositions including a benzhydrylsulfinylacetamide antidepressant and an amount of sodium chloride effective to increase a mean arterial blood pressure of a subject and methods for ameliorating symptoms of dementia including forms of dementia diagnosed as Alzheimer's disease and side-effects associated with the administration of cognition effecting pharmaceuticals.

Claim (Index 9):
The method of  claim 8 , wherein the dementia is diagnosed as Alzheimer's disease.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 97.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15409775', '15409655', '16090142', '12689957', '16119439']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7006291803422694
- 35 USC 102 Novelty (BERT): 0.4996692431129134
- Combined Prediction Score: 0.6805331866193338
- Mean Citation Score: 188.03500000000005
- Max Citation Score: 198.47554
- Similarity Product: 136.67287202635288

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test